Evidence map›Paper›PMID 15132435›Full record

ArticleHippocampus2004

P/Q Ca2+ channel blockade stops spreading depression and related pyramidal neuronal Ca2+ rise in hippocampal organ culture.

Phillip E Kunkler, Richard P Kraig

Open access · greenAbstract read
In one paragraph

Article in Hippocampus, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. P/Q-type calcium channel modulators.British journal of pharmacology · 2012
    Review
  11. Article
  12. Migraine is a neuronal disease.Journal of neural transmission (Vienna, Austria : 1996) · 2011
    Review
  13. Strategies for study of neuroprotection from cold-preconditioning.Journal of visualized experiments : JoVE · 2010
    Article
  14. Gabapentin suppresses cortical spreading depression susceptibility.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2010
    Article
  15. The neurobiology of migraine.Handbook of clinical neurology · 2010
    Article
  16. Cortical spreading depression-new insights and persistent questions.Cephalalgia : an international journal of headache · 2009
    Article
  17. Review
  18. Article
  19. Zn2+ influx is critical for some forms of spreading depression in brain slices.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Phillip E KunklerDepartment of Neurology, MC 2030, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA. pkunkler@neurology.bsd.uchicago.edu
Richard P Kraig
University of Chicago · US

Funding

HYDROGEN IONS AND BRAIN INFARCTIONR01NS019108 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI KRAIG, RICHARD P · 1985 to 2019
$5.2M
NINDS NIH HHS NS-19108NINDS NIH HHS R01 NS019108
6 · The paper itself

Abstract

Ca2+ channels and pyramidal cell Ca2+ are involved in hippocampal spreading depression (SD), but their roles remain elusive. Accordingly, we characterized Ca2+ changes during SD in CA3 pyramidal neurons and determined whether Ca2+ channel antagonists could prevent SD. SD was induced in hippocampal organotypic cultures (HOTCs), in which experimental conditions can be rigorously controlled. SD was triggered by transient exposure to sodium acetate (NaAc)-based Ringer's coupled to an electrical pulse in the dentate gyrus and its occurrence confirmed with interstitial DC recordings. Pyramidal cell Ca2+ was measured with fura-2 filled cells and was quantified at the soma, proximal and more distal apical dendrites. Regional Ca2+ changes began simultaneously with the triggering pulse of SD and reached three distinct peaks before returning to baseline concomitant with the interstitial DC potential of SD. The first peak occurred within 5 s of the triggering pulse, was smallest, and heralded the onset of SD. The second Ca2+ change was the greatest and reached a peak 6 s later, during the early phase of SD. The third was intermediate in size and occurred 18 s later, as SD reached its maximum interstitial DC change. SD was prevented by nonselective Ca2+ blockade (Ni2+ and Cd2+) but not by either L-Ca2+ channel (nifedipine) or N-Ca2+ channel inhibition (omega-conotoxin GVIA). Importantly, SD was blocked by P/Q Ca2+ channel antagonism (omega-agatoxin-IVA), which also prompted a significant reduction in pyramidal cell Ca2+ change and hyperexcitability. These results show that the spatiotemporal pattern of pyramidal cell Ca2+ change with SD is multiphasic; they provide further evidence that these changes begin before electrophysiologic evidence of SD. Furthermore, they show that P/Q Ca2+ channel antagonism can prevent SD in HOTCs and it appears to do so by preventing the NaAc-induced increased pyramidal cell excitability from NaAc exposure, which may involve altered GABAergic transmission.

Indexed as

Action PotentialsAnimalsCalciumCalcium Channel BlockersCalcium ChannelsCalcium Channels, P-TypeCalcium Channels, Q-TypeCalcium SignalingCortical Spreading DepressionDentate GyrusElectric StimulationHippocampusIn Vitro TechniquesNeural PathwaysPyramidal CellsSodium AcetateCalciumCalcium Channel BlockersCalcium ChannelsCalcium Channels, P-TypeCalcium Channels, Q-TypeSodium Acetate

Identifiers

PMID15132435
PMCPMC2807125
OpenAlexW2046371346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.